10:35 AM EST - Nabis Holdings Inc. : Announced that it has entered into an agreement to purchase 2,260,500 common shares, representing a 49% interest, of Cannova Medical Ltd., a provider of innovative solutions for cannabis consumption, and to acquire the remaining 51% interest at the option of Nabis. Cannova, based in Israel, has developed an alternative solution for cannabis consumption using a sublingual strip infused with a variety of active cannabis substances. The product has proven qualities that allow producers to more effectively control dosage quantities, combine the Cannabis with other natural active ingredients to create a set of products for a variety of needs and lifestyles. In connection with the Transaction, Nabis will have Exclusive Distribution rights in North America. Nabis Holdings Inc.
shares NAB:CNX are trading up 2.08 percent at $0.49.
